Companies / Champions Oncology, Inc.

Champions Oncology, Inc.

Nasdaq: CSBRCIK 771856BALTIMORE, MDchampionsoncology.com ↗

Financials · FY2026

Revenue$59.42M
Net income$-1.18M
Total debt—
Cash$7.13M
Diluted EPS$-0.08
Shares outstanding13.9M

Ownership

13.9M shares outstanding · as of Jul 23, 2026
41.3%Institutions
Ownership
Institutions41.35%5,744,721
Public float58.65%8,148,848

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 1

View all →
Insider% of sharesShares
Brainin Robert LawrenceCEOCEO · Director
——

Institutional holders 27

View all →
HolderValue% of shares
Battery Management Corp.$16.73M17.43%
NEA Management Company, LLC$11.84M12.33%
Vanguard Group Inc$2.31M2.41%
Tocqueville Asset Management L.P.$2.21M2.30%
Morgan Stanley$1.59M1.65%
Renaissance Technologies LLC$836.8K1.05%
BlackRock, Inc.$799.9K0.93%
Mink Brook Asset Management LLC$554.9K0.58%
Geode Capital Management, LLC$443.9K0.56%
Northern Trust Corp$318.9K0.33%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jul 16, 2025Brainin Robert Lawrence
CEO
GrantOption to purchase Common Stock—+100K
+14.83%
774,163
5.57% of shares
low
Jul 16, 2025Brainin Robert Lawrence
CEO
GrantOption to purchase Common Stock—+100K
+17.42%
674,163
4.85% of shares
low
Jul 16, 2025Brainin Robert Lawrence
CEO
GrantOption to purchase Common Stock—+150K
+35.36%
574,163
4.13% of shares
low
Jul 16, 2025Brainin Robert Lawrence
CEO
GrantOption to purchase Common Stock—+63K
+17.28%
424,163
3.05% of shares
low
Jul 16, 2025Brainin Robert Lawrence
CEO
GrantOption to purchase Common Stock—+63K
+20.89%
361,663
2.60% of shares
low
Jul 16, 2025Brainin Robert Lawrence
CEO
GrantOption to purchase Common Stock—+225K
+303.39%
299,163
2.15% of shares
low
Nov 12, 2024Brainin Robert Lawrence
CEO
GrantOption to purchase Common Stock—+23K
+45.04%
74,163
0.53% of shares
low
Nov 3, 2023Brainin Robert Lawrence
CEO
GrantOption to purchase Common Stock—+19K
+59.48%
51,133
0.37% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
CSBRCommon StockEquity15870P307BBG000BYGPJ9